PROM1 and neoplasm: Immunostaining of these xenografts further revealed that the tumors derived from CD133+ cells contained both CD133+ and CD133- cells and the proportion of CD133- cells was significantly greater than the ~7% of contaminating CD133- cells that were present in the tumor cell inoculation (Fig 5C; right panel).